Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARR
1901
Armour Residential REIT
ARR
$2.33B
| $4.62M | ﹤0.01% |
+51,744
| New | +$4.42M |
|
1902
Caesarstone
CSTE
$72.3M
| $4.62M | ﹤0.01% |
306,766
+33,006
| +12% | +$530K |
|
1903
Worthington Enterprises
WOR
$2.75B
| $4.61M | ﹤0.01% |
177,122
-132,680
| -43% | -$3.12M |
|
1904
Hawkins
HWKN
$2.67B
| $4.59M | ﹤0.01% |
200,400
+5,800
| +3% | +$123K |
|
1905
Amphenol
APH
$198B
| $4.59M | ﹤0.01% |
169,600
-140,400
| -45% | -$3.58M |
|
|
WIRE
1906
DELISTED
Encore Wire Corp
WIRE
| $4.59M | ﹤0.01% |
79,900
-26,137
| -25% | -$1.5M |
|
1907
Compañía de Cervecerías Unidas
CCU
$2.12B
| $4.58M | ﹤0.01% |
241,200
-100,700
| -29% | -$2M |
|
|
EB
1908
DELISTED
Eventbrite
EB
| $4.54M | ﹤0.01% |
225,100
+72,100
| +47% | +$1.38M |
|
1909
Transact Technologies
TACT
$53.2M
| $4.54M | ﹤0.01% |
413,600
+9,834
| +2% | +$113K |
|
|
ITI
1910
DELISTED
Iteris, Inc.
ITI
| $4.54M | ﹤0.01% |
909,200
+4,426
| +0.5% | +$22.5K |
|
1911
First Mid Bancshares
FMBH
$1.39B
| $4.53M | ﹤0.01% |
128,512
-3,200
| -2% | -$112K |
|
1912
VEON
VEON
$3.62B
| $4.52M | ﹤0.01% |
71,462
-44,896
| -39% | -$2.76M |
|
|
ARQL
1913
DELISTED
Arqule Inc
ARQL
| $4.51M | ﹤0.01% |
225,782
-435,291
| -66% | -$5.05M |
|
1914
Ovid Therapeutics
OVID
$414M
| $4.5M | ﹤0.01% |
1,084,709
+497,984
| +85% | +$1.57M |
|
1915
Zions Bancorporation
ZION
$10.2B
| $4.49M | ﹤0.01% |
86,395
-340,100
| -80% | -$16.5M |
|
1916
KT
KT
$8.62B
| $4.48M | ﹤0.01% |
+386,145
| New | +$4.4M |
|
1917
Fabrinet
FN
$15.6B
| $4.47M | ﹤0.01% |
69,000
+27,000
| +64% | +$1.56M |
|
1918
Vornado Realty Trust
VNO
$7.41B
| $4.47M | ﹤0.01% |
67,175
-105,124
| -61% | -$6.8M |
|
1919
Nicolet Bankshares
NIC
$3.6B
| $4.46M | ﹤0.01% |
60,395
-28,700
| -32% | -$2.02M |
|
1920
Global Indemnity Group
GBLI
$402M
| $4.45M | ﹤0.01% |
150,327
-4,437
| -3% | -$118K |
|
|
GSH
1921
DELISTED
Guangshen Railway Co. Ltd
GSH
| $4.45M | ﹤0.01% |
268,261
+4,600
| +2% | +$74.2K |
|
1922
Rocky Mountain Chocolate Factory
RMCF
$7.93M
| $4.44M | ﹤0.01% |
481,121
+5,020
| +1% | +$44.9K |
|
1923
Travelers Companies
TRV
$78.1B
| $4.43M | ﹤0.01% |
+32,372
| New | +$4.41M |
|
|
PETQ
1924
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $4.43M | ﹤0.01% |
176,800
-217,100
| -55% | -$5.39M |
|
1925
Alico
ALCO
$280M
| $4.42M | ﹤0.01% |
123,341
+37,917
| +44% | +$1.28M |
|
Similar funds
Renaissance Technologies's Q4 2019 Portfolio in Review
As of Q4 2019, Renaissance Technologies held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Renaissance Technologies's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Renaissance Technologies fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Renaissance Technologies's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Renaissance Technologies opened 518 new positions and closed 443 in Q4 2019.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.